000 01558 a2200457 4500
005 20250518005608.0
264 0 _c20190606
008 201906s 0 0 eng d
022 _a1432-1041
024 7 _a10.1007/s00228-018-2591-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKettunen, Reetta
245 0 0 _aDuration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cMar 2019
300 _a417-425 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAntidepressive Agents
_xadministration & dosage
650 0 4 _aAntipsychotic Agents
_xadministration & dosage
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aFinland
650 0 4 _aHumans
650 0 4 _aIndependent Living
650 0 4 _aMale
650 0 4 _aProportional Hazards Models
650 0 4 _aRegistries
650 0 4 _aSex Factors
650 0 4 _aTime Factors
700 1 _aTaipale, Heidi
700 1 _aTolppanen, Anna-Maija
700 1 _aTanskanen, Antti
700 1 _aTiihonen, Jari
700 1 _aHartikainen, Sirpa
700 1 _aKoponen, Marjaana
773 0 _tEuropean journal of clinical pharmacology
_gvol. 75
_gno. 3
_gp. 417-425
856 4 0 _uhttps://doi.org/10.1007/s00228-018-2591-5
_zAvailable from publisher's website
999 _c29029595
_d29029595